Aureus Asset Management LLC Has $2.87 Million Stake in Danaher Co. (NYSE:DHR)

Aureus Asset Management LLC decreased its position in shares of Danaher Co. (NYSE:DHR) by 21.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,304 shares of the conglomerate’s stock after selling 2,816 shares during the period. Aureus Asset Management LLC’s holdings in Danaher were worth $2,865,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of DHR. FMR LLC lifted its position in Danaher by 15.8% during the 3rd quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock worth $6,566,116,000 after acquiring an additional 3,217,631 shares during the last quarter. TD Asset Management Inc increased its holdings in shares of Danaher by 99.0% during the 2nd quarter. TD Asset Management Inc now owns 1,358,706 shares of the conglomerate’s stock worth $339,473,000 after purchasing an additional 675,952 shares during the period. Massachusetts Financial Services Co. MA increased its holdings in shares of Danaher by 22.7% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 3,047,728 shares of the conglomerate’s stock worth $761,475,000 after purchasing an additional 563,546 shares during the period. International Assets Investment Management LLC increased its holdings in shares of Danaher by 40,196.5% during the 3rd quarter. International Assets Investment Management LLC now owns 429,964 shares of the conglomerate’s stock worth $119,539,000 after purchasing an additional 428,897 shares during the period. Finally, Montrusco Bolton Investments Inc. increased its holdings in shares of Danaher by 30.4% during the 3rd quarter. Montrusco Bolton Investments Inc. now owns 1,705,884 shares of the conglomerate’s stock worth $465,617,000 after purchasing an additional 397,671 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on DHR shares. Stifel Nicolaus boosted their price objective on shares of Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a report on Wednesday, October 23rd. StockNews.com upgraded shares of Danaher from a “hold” rating to a “buy” rating in a report on Wednesday, November 27th. Wells Fargo & Company started coverage on shares of Danaher in a report on Tuesday, August 27th. They set an “equal weight” rating and a $280.00 price objective on the stock. Stephens restated an “overweight” rating and set a $315.00 price objective on shares of Danaher in a report on Wednesday, October 23rd. Finally, Barclays lowered their target price on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 23rd. Five equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and a consensus price target of $287.16.

Danaher Price Performance

Shares of Danaher stock opened at $239.69 on Monday. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $173.12 billion, a price-to-earnings ratio of 45.74, a P/E/G ratio of 4.41 and a beta of 0.85. Danaher Co. has a 1-year low of $215.68 and a 1-year high of $281.70. The firm’s 50-day moving average price is $254.59 and its two-hundred day moving average price is $259.41.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The company had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. During the same period in the prior year, the business earned $2.02 earnings per share. Danaher’s quarterly revenue was up 3.1% on a year-over-year basis. On average, equities analysts predict that Danaher Co. will post 7.5 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were given a dividend of $0.27 per share. The ex-dividend date was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.45%. Danaher’s payout ratio is 20.61%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.